Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.

CompletedOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

April 22, 2022

Study Completion Date

October 23, 2023

Conditions

Malaria

Trial Locations (2)

GSK Investigational Site, Kisumu

GSK Investigational Site, Kumasi